(2S,4S,6S,8S,10S,12S,14S)-(2R,3R,4S,5R,6R)-3-(benzyloxy)-6-(((5aR,6R,8R,9R,9aS)-9-(benzyloxy)-8-(hydroxymethyl)-2,2,4,4-tetraisopropyltetrahydro-5aH-pyrano[3,4-f][1,3,5,2,4]trioxadisilepin-6-yl)oxy)-2-(hydroxymethyl)-5-(palmitoyloxy)tetrahydro-2H-pyran-4-yl 2,4,6,8,10,12,14-heptamethyltriacontanoate 、
(2S,4S,6S,8S,10R,12R,14R,16R,17R)-2,4,6,8,10,12,14,16-octamethyl-17-phenylmethoxydotriacontanoic acid 在
4-二甲氨基吡啶 、
盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下,
以
二氯甲烷 为溶剂,
反应 22.0h,
以71%的产率得到(2S,4S,6S,8S,10R,12R,14R,16R,17R)-((5aR,6R,8R,9R,9aS)-9-(benzyloxy)-6-((2R,3R,4S,5R,6R)-5-(benzyloxy)-6-(((2S,4S,6S,8S,10R,12R,14R,16R,17R)-17-(benzyloxy)-2,4,6,8,10,12,14,16-octamethyldotriacontanoyloxy)methyl)-4-((2S,4S,6S,8S,10S,12S,14S)-2,4,6,8,10,12,14-heptamethyltriacontanoyloxy)-3-(palmitoyloxy)tetrahydro-2H-pyran-2-yloxy)-2,2,4,4-tetraisopropyltetrahydro-5aH-pyrano[3,4-f][1,3,5,2,4]trioxadisilepin-8-yl)methyl 17-(benzyloxy)-2,4,6,8,10,12,14,16-octamethyldotriacontanoate